Signal pathways of cell proliferation and death as targets of potential chemotherapeutics
REPICKÝ A.1, JANTOVÁ S.1, MILATA V.2
1Slovenská technická univerzita v Bratislave, Fakulta chemickej a potravinárskej technológie, Ústav biochémie, výživy a ochrany zdravia 2Slovenská technická univerzita Bratislava, Fakulta chemickej a potravinárskej technológie, Ústav organickej chémie, katalýzy a petrochémie |
|
Summary:
The purpose of this paper is to review current information concerning signal transduction pathways
of cell proliferation and cell death applicable in the research of antitumor compounds with a specific
effect. Actually, cancer counts among the world gravest diseases. Research of the mechanisms of
action of chemotherapeutics helps us to find compounds with high cytotoxic activity to tumor cells
and low or no cytotoxicity to normal cells. Many present studies deal with the ability of drugs to hit
the proliferation signal pathways or cell death pathways specifically. Various proliferation signal
pathways have been identified, e.g. pathways of mitogen-activated proteinkinases. In original rovstudies,
cell death was considered to perform in necrotic and apoptotic forms, whereas in contrast
to necrosis, apoptosis represented the programmed process. However, other forms of programmed
cell death were discovered, the programmed necrosis and autophagic cell death. Similarly, beside
the intrinsic, mitochondrial-mediated, and extrinsic, receptor-mediated pathways, new mechanisms
of induction of apoptosis were discovered: the endoplasmic reticulum stress pathway in which
calcium plays an important role, the lysosomal pathway and the ceramide-induced pathway. Current
information concerning transduction of antiproliferative and death stimuli in cells allows to explain
the mechanisms of action of known drugs and also brings novel therapeutical targets which can
serve in treatment of such diseases as cancer.
Key words:
cell proliferation – MAPK – programmed cell death – apoptotic pathways
|